Back

Comparative clinical outcomes of nebivolol versus bisoprolol in patients with STEMI after primary PCI: a propensity-score matched analysis

29 August 2026 (14:15 - 14:45)
Organised by: Logo
Congress Presentation Part of: Acute myocardial infarction: contemporary challenges ST-Elevation Myocardial Infarction (STEMI) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Ji Young Park

Eulji University Hospital, Deajeon (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
Impact of coronary artery ectasia on revascularization strategies and echocardiographic characteristics in patients presenting with ST-segment elevation myocardial infarction
Doctor L. Caunite (Leiden, NL)
Abstract
Presentation thumbnail
Contemporary heart failure and mortality burden after STEMI: insights from a real-world cohort
Doctor R. Aggarwal (Boston, US)
Abstract
Presentation thumbnail
Selection matters: clinical indication, not timing, determines angiographic success in late-presenting STEMI
Doctor A. Zambrano Zambrano (Mexico City, MX)
Abstract
Presentation thumbnail
Clonal hematopoiesis of indeterminate potential and stress hyperglycemia ratio among patients with STEMI---from a prospective cohort study
Ms L. Xue (CN)
Abstract

Access the full session

Session thumbnail
Acute myocardial infarction: contemporary challenges

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of Carvedilol versus Bisoprolol on long-term clinical outcomes in STEMI patients with mid-range LVEF
1 September 2025
thumbnail
ESC Journals
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry
19 October 2022
thumbnail
Congress Presentation
Impact of morphine use on mortality in STEMI patients treated with primary PCI - preliminary data from a new registry
15 April 2021
thumbnail
Congress Presentation
Reduction of cardiovascular events in patients with cardiovascular disease with the CV-polypill: a retrospective and propensity score matching study
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources